SC
SCL Science Inc.
246960 | KO
Overview
Corporate Details
- ISIN(s):
- KR7246960009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 선유로13길 25 에이스하이테크시티 2차 1209호, 서울특별시
- Website:
- https://sclscience.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
M&A Activity
타법인주식및출자증권취득결정(자율공시)
|
Korean | 16.2 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-08-14 00:00 |
Regulatory Filings
단일판매ㆍ공급계약체결
|
Korean | 10.4 KB | ||
| 2025-08-14 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.7 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 114.2 KB | ||
| 2025-07-28 00:00 |
Delisting Announcement
주권매매거래정지 (영업양수도)
|
Korean | 4.8 KB | ||
| 2025-07-28 00:00 |
M&A Activity
주요사항보고서(영업양수결정)
|
Korean | 18.8 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(무상증자결정)
|
Korean | 15.0 KB |
Automate Your Workflow. Get a real-time feed of all SCL Science Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SCL Science Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SCL Science Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.
Denmark
GUBRA
Denmark
GUBRA
Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.
United States of America
HALO
United States of America
HALO
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
Japan
4593
AI-powered ECG technology for early detection of heart disease and advanced diagnostics.
United States of America
HSCS
United States of America
HSCS
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A
Japan
219A
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland
HRTIS
Finland
HRTIS
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland
HPE
Poland
HPE
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea
046210
South Korea
046210
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea
343090
South Korea
343090